Exploratory Observation of Regimens After LAA Occlusion by LAMax LAAC® Device for Subjects With High Risk of Bleeding
Status:
Recruiting
Trial end date:
2024-08-23
Target enrollment:
Participant gender:
Summary
This is a prospective, single-center, randomized, exploratory clinical observation to explore
the overall benefit of optimized anticoagulation and antithrombotic regimens after left
atrial appendage occlusion by LAMax LAAC® occluder for subjects with non-valvular atrial
fibrillation (AF) at high risk of bleeding (HAS-BLED score ≥ 3).
Phase:
N/A
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University